C88.40 رمز محدد قابل للفوترة Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission
ICD-10-CM C88.40 identifies “Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
الفصل 2: Neoplasms
تعليمات الرمز
Inclusion terms8
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] NOS
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] with failed remission
- Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] NOS
- Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] not having achieved remission
- Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] with failed remission
- Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] NOS
- Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] not having achieved remission
- Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] with failed remission
تعليمات المستويات الأعلى
الفصول 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C88 · Malignant immunoproliferative diseases and certain other B-cell lymphomas
C88.4 · Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
Inclusion terms2
- Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma]
- Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma]
Excludes 11
high malignant (diffuse large B-cell) lymphoma (C83.3-)
مراجع الفهرس الرسمي
سجل التحويل الرسمي
تدعم التعيينات التاريخية من جدول التحويل لدى CDC استرجاع البيانات، ولا تتيح استبدال الرمز الحالي برمز سابق.
فترة الإصدار 2024-10-01
التعيين السابق: C88.4
السجل
سجل الرمز
آخر تغيير مسجل · FY2025
تغيّردون تغيير
FY2025
يسري من
- أُضيف
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission
رمز تشخيص قابل للفوترة
CDC/NCHS · FY2025جميع الإصدارات (5)
| جميع الإصدارات | يسري من | سجل الرمز |
|---|---|---|
| FY2025 | 2024-10-01 | أُضيف |
| FY2025 · 04-01 | 2025-04-01 | لا تغيير في القائمة الجدولية |
| FY2026 | 2025-10-01 | لا تغيير في القائمة الجدولية |
| FY2026 · April | 2026-04-01 | لا تغيير في القائمة الجدولية |
| FY2027 | 2026-10-01 | لا تغيير في القائمة الجدولية |
هذا المدخل رمز مكتمل في الإصدار المحدد. لا يثبت التحقق المرجعي الملاءمة السريرية ولا يضمن التعويض.